2017年12月27日星期三

Creating an artificial tail anchor as a novel strategy to enhance the potency of peptide-based HIV fusion inhibitors

Creating an artificial tail anchor as a novel strategy to enhance the potency of peptide-based HIV fusion inhibitors

S Su, Y Zhu, S Ye, Q Qi, S Xia, Z Ma, F Yu… - Journal of …, 2017 - Am Soc Microbiol
ABSTRACT 20 (enfuvirtide) and other peptides derived from the human immunodeficiency
virus type 1 (HIV-1) gp41 C-terminal heptad repeat (CHR) region inhibit HIV fusion by
binding to the hydrophobic grooves on the N-terminal heptad repeat (NHR) trimer and 



For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论